These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Cysts of PRKCSH mutated polycystic liver disease patients lack hepatocystin but express Sec63p. Waanders E, Croes HJ, Maass CN, te Morsche RH, van Geffen HJ, van Krieken JH, Fransen JA, Drenth JP. Histochem Cell Biol; 2008 Mar; 129(3):301-10. PubMed ID: 18224332 [Abstract] [Full Text] [Related]
12. Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management. Cnossen WR, Drenth JP. Orphanet J Rare Dis; 2014 May 01; 9():69. PubMed ID: 24886261 [Abstract] [Full Text] [Related]
13. PRKCSH/80K-H, the protein mutated in polycystic liver disease, protects polycystin-2/TRPP2 against HERP-mediated degradation. Gao H, Wang Y, Wegierski T, Skouloudaki K, Pütz M, Fu X, Engel C, Boehlke C, Peng H, Kuehn EW, Kim E, Kramer-Zucker A, Walz G. Hum Mol Genet; 2010 Jan 01; 19(1):16-24. PubMed ID: 19801576 [Abstract] [Full Text] [Related]
14. Inhibition of Cdc25A suppresses hepato-renal cystogenesis in rodent models of polycystic kidney and liver disease. Masyuk TV, Radtke BN, Stroope AJ, Banales JM, Masyuk AI, Gradilone SA, Gajdos GB, Chandok N, Bakeberg JL, Ward CJ, Ritman EL, Kiyokawa H, LaRusso NF. Gastroenterology; 2012 Mar 01; 142(3):622-633.e4. PubMed ID: 22155366 [Abstract] [Full Text] [Related]
15. Isolated polycystic liver disease genes define effectors of polycystin-1 function. Besse W, Dong K, Choi J, Punia S, Fedeles SV, Choi M, Gallagher AR, Huang EB, Gulati A, Knight J, Mane S, Tahvanainen E, Tahvanainen P, Sanna-Cherchi S, Lifton RP, Watnick T, Pei YP, Torres VE, Somlo S. J Clin Invest; 2017 May 01; 127(5):1772-1785. PubMed ID: 28375157 [Abstract] [Full Text] [Related]
16. Abnormal hepatocystin caused by truncating PRKCSH mutations leads to autosomal dominant polycystic liver disease. Drenth JP, Tahvanainen E, te Morsche RH, Tahvanainen P, Kääriäinen H, Höckerstedt K, van de Kamp JM, Breuning MH, Jansen JB. Hepatology; 2004 Apr 01; 39(4):924-31. PubMed ID: 15057895 [Abstract] [Full Text] [Related]
17. IFT-A deficiency in juvenile mice impairs biliary development and exacerbates ADPKD liver disease. Wang W, Pottorf TS, Wang HH, Dong R, Kavanaugh MA, Cornelius JT, Dennis KL, Apte U, Pritchard MT, Sharma M, Tran PV. J Pathol; 2021 Jul 01; 254(3):289-302. PubMed ID: 33900625 [Abstract] [Full Text] [Related]
20. A genetic interaction network of five genes for human polycystic kidney and liver diseases defines polycystin-1 as the central determinant of cyst formation. Fedeles SV, Tian X, Gallagher AR, Mitobe M, Nishio S, Lee SH, Cai Y, Geng L, Crews CM, Somlo S. Nat Genet; 2011 Jun 19; 43(7):639-47. PubMed ID: 21685914 [Abstract] [Full Text] [Related] Page: [Next] [New Search]